Advertisement

Indications and Results of Liver Transplantation for Primary and Metastatic Liver Cancer

  • Alan Koffron
  • Jonathan P. Fryer
  • Michael Abecassis
Part of the Cancer Treatment and Research book series (CTAR, volume 109)

Abstract

Orthotopic liver transplantation (OLT) has become an established treatment for end-stage liver disease (ESLD), acute liver failure, and malignant tumors. Transplantation for hepatic malignancies is indicated in the setting of either unresectible lesion(s), or coexistent cirrhosis resulting in both inadequate hepatic reserve and prohibitive portal hypertension.

Keywords

Hepatocellular Carcinoma Liver Transplantation Vascular Invasion Orthotopic Liver Transplantation Portal Vein Embolization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 321:1014–1022, 1092–1099, 1989.PubMedCrossRefGoogle Scholar
  2. 2.
    Klintmalm GB, Stone MJ. Liver transplantation for malignancy. Transplant Rev 4:52–8, 1990.CrossRefGoogle Scholar
  3. 3.
    Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc 20(suppl) l):478–82, 1988.PubMedGoogle Scholar
  4. 4.
    Olthoff KM, Millis JM, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125:1261–8, 1990PubMedCrossRefGoogle Scholar
  5. 5.
    O’Grady JG, Poison RJ, Rolles K, et al. Liver transplantation for malignant disease. Ann Surg 207:373–9, 1988PubMedCrossRefGoogle Scholar
  6. 6.
    Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 202:401–7, 1985PubMedCrossRefGoogle Scholar
  7. 7.
    Pichlmayr R, Ringe B, Bechstein WO, et al. Approach to primary liver cancer. Recent Results Cancer Research 110:65–73, 1988CrossRefGoogle Scholar
  8. 8.
    Ringe B, Wittekind C, Bechstein, WO, et al. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 209:88–98, 1989PubMedCrossRefGoogle Scholar
  9. 9.
    Perm I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110:726–35, 1991Google Scholar
  10. 10.
    Carr BI, Kar S. An assay for hepatoma micrometastases: albumin gene expression in peripheral blood from patients with advanced hepatocellular carcinoma (HCC) (abstr). Hepatology 14:108A, 1991Google Scholar
  11. 11.
    Neuhaus P, Broelsch CE, Ringe B, Pichlmayr R. Liver transplantation for liver tumors. Recent Results Cancer Research. 100:221–8, 1986.CrossRefGoogle Scholar
  12. 12.
    Koneru B, Cassaville A, Bowman J, et al. Liver transplantation for malignant tumors. Gastroenterology Clin North Amer 17:177–93, 1988.Google Scholar
  13. 13.
    Jenkins RL, Pinson CW, Stone MD. Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 23(Suppl):S 104–9, 1989.CrossRefGoogle Scholar
  14. 14.
    Pichlmayr R. Indications for liver grafting in hepatic tumors. In Bannasch P, Keppler D, Weber G, eds. Liver Cell Carcinoma. Boston, Kluwer Academic, 1989, pp 491–7.Google Scholar
  15. 15.
    Flye MW, McCullough CS. Liver transplantation for malignant disease. Principles Pract Oncol 3:1–12,1989.Google Scholar
  16. 16.
    Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–93, 1990.PubMedGoogle Scholar
  17. 17.
    Ismail T, Angrisani I, Gunson B, et al, Primary hepatic malignancy: the role of liver transplantation. Br JSWg 77:983–7, 1990.CrossRefGoogle Scholar
  18. 18.
    Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15:270–85, 1991.PubMedCrossRefGoogle Scholar
  19. 19.
    Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221–9, 1991.PubMedCrossRefGoogle Scholar
  20. 20.
    Stevens L, Piper J, Emond J, et al. Liver transplantation for controversial indications: alcoholic liver disease, hepatic cancers, and viral hepatitis. Transplant Proc 23:1915–6, 1991.PubMedGoogle Scholar
  21. 21.
    Van Thiel DH, Carr B, Iwatsuki S, et al. Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc 23:1917–21,1991.PubMedGoogle Scholar
  22. 22.
    Van Thiel DH, Carr BI, Yokoyama I, et al. Liver transplantation as a treatment of hepatocellular carcinoma. In Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, TX, Gulf, 1991, pp 309–15.Google Scholar
  23. 23.
    Haug CE, Jenkins RL, Rohrer RJ, et al. Liver transplantation for primary hepatic cancer. Transplantation 53:376–82, 1992.PubMedCrossRefGoogle Scholar
  24. 24.
    Ellis LM, Demers MI, Roh MS. Current strategies for the treatment of hepatocellular carcinoma. Curr Opin Oncol 4:741–51, 1992.PubMedCrossRefGoogle Scholar
  25. 25.
    Stone MJ, Klintmalm G, Polter D, et al. Neoadjuvant chemotherapy and orthotopic liver transplantation for hepatocellular carcinoma. Transplantation 48:344–7, 1989.PubMedCrossRefGoogle Scholar
  26. 26.
    Stone MI, Klintmalm GBG, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 104:196–202, 1993.PubMedGoogle Scholar
  27. 27.
    Ahlgren JD.Neoplasms of the hepatobiliary system. In Calbresi P, Schein PS, eds. Medical Oncology. New York, McGraw-Hill, 1993, pp, 713–39.Google Scholar
  28. 28.
    Craig JR, Peters RJ, Edmondson HA. Tumors of the Liver and Intrahepatic Bile Ducts. Washington, DC: Armed Forces Institute of Pathology, 1989.Google Scholar
  29. 29.
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N EnglJ Med 340:745–50, 1999.CrossRefGoogle Scholar
  30. 30.
    Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular-cholangiocarcinoma. Cancer 55:124–35, 1985.PubMedCrossRefGoogle Scholar
  31. 31.
    McPeake J, and Williams R. Liver transplantation for malignancy: the current position. In Terblanche J, ed. Hepatobiliary Malignancy, It’s Multidisciplinary Management, Edward Arnold, London, 1994, pp 595–618.Google Scholar
  32. 32.
    Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 155: 49–54, 1990.CrossRefGoogle Scholar
  33. 33.
    Dodd GD, Miller WJ, Baron RL, Skolnick ML, Campbell WL. Detection of malignant tumours in end-stage cirrhotic livers: efficacy of sonography as a screening technique. Am J Roentgenol 159: 727–33, 1992.CrossRefGoogle Scholar
  34. 34.
    Miller WJ, Federle MP, Campbell WL. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients. Amer J Roentgenol 157:303–6, 1991.CrossRefGoogle Scholar
  35. 35.
    Parker G A, Lawrence W, Horsley S, et al. Intraoperative ultrasound of the liver affects operative decision making. Ann Surg 209:569–77, 1989.PubMedCrossRefGoogle Scholar
  36. 36.
    Kudo M. Imaging Diagnosis of Hepatocellular Carcinoma. Seminars in Liver Disease 19;297–310, 1999.PubMedCrossRefGoogle Scholar
  37. 37.
    Tsunetomi S, Ohto M, lino Y, et al. Diagnosis of small hepatocellular carcinoma by computed tomography: correlation of CT findings and histopathology. J Gastroenterol Hepatol 4:395–404, 1989.PubMedCrossRefGoogle Scholar
  38. 38.
    Sitzmann JV, Coleman J, Pitt HA, et al. Preoperative assessment of malignant hepatic tumors. Am Surg 159:137–43, 1990.CrossRefGoogle Scholar
  39. 39.
    Rummeny E, Weissleder R, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. Am J Roentgenol 159:137–43, 1989.Google Scholar
  40. 40.
    Muramatsu Y, Nawano S, Takayasu K, et al. Early hepatocellular carcinoma: MR imaging. Radiology 181:209–13, 1991.PubMedGoogle Scholar
  41. 41.
    Cohen MB, Haber MM, Holly EA, et al. Cytologic criteria to distinguish hepatocellular carcinoma from normoplastic liver. Am J Clin Pathol 95:125–30, 1991.PubMedGoogle Scholar
  42. 42.
    Beahrs OH, Henson DE, Hutter RVP, Kennedy W, eds. Manual for Staging of Cancer. Philadelphia, JB Lippincott, 1992, pp 89–91.Google Scholar
  43. 43.
    Foster JH. Evaluation of asymptomatic solitary hepatic lesions. Ann Rev Med 39:85–93, 1988.PubMedCrossRefGoogle Scholar
  44. 44.
    Rummeny E, Weissleder IT, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. Am J Roentgenol 152:63–72, 1989.CrossRefGoogle Scholar
  45. 45.
    Ferrucci JT. Liver tumor imaging. Cancer 67:1189–95, 1991.PubMedCrossRefGoogle Scholar
  46. 46.
    Miller WJ, Federle MP, Campbell WL. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients. Am J Roentgenol 157:303–6, 1991CrossRefGoogle Scholar
  47. 47.
    Johnson CD. Magnetic resonance imaging of the liver, current clinical applications. Mayo Clin Proc 68:147–56, 1993.PubMedCrossRefGoogle Scholar
  48. 48.
    Edelman RR, Warach S. Magnetic resonance imaging. N Engl J Med 328:708–16,785–91, 1993.Google Scholar
  49. 49.
    Calne RY, Williams R, Rolles K. Liver transplantation in the adult. World J SVg 10: 422–31, 1986.CrossRefGoogle Scholar
  50. 50.
    Krom RA, Gips CH, Houthoff HJ, et al. Orthotopic liver transplantation in Groningen, The Netherlands (1979–1983). Hepatology 4(suppl):61S-65S, 1984.CrossRefGoogle Scholar
  51. 51.
    Di Bisceglie AM, Rustgi VY, Hoofhagle JH, et al. Hepatocellular carcinoma. Ann Intern Med 108:390–401, 1988.PubMedGoogle Scholar
  52. 52.
    Ahlgren JD, Wanebo HJ, Hill MC. Hepatocellular carcinoma. In Ahlgren JD, Macdonald JS, eds. Gastrointestinal Oncology. Philadelphia, JB Lippincott, 1992, pp 417–36.Google Scholar
  53. 53.
    Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 15:1–31, 1988.PubMedCrossRefGoogle Scholar
  54. 54.
    Falkson G, Cnaan A, Schutt AJ, et al. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 48:7314–8, 1988.PubMedGoogle Scholar
  55. 55.
    Falkson G. Treatment for patients with hepatocellular carcinoma: state-of-the-art. Ann Oncol 3:336–7, 1992.PubMedGoogle Scholar
  56. 56.
    Taketa K. a-fetoprotein: réévaluation in hepatology. Hepatology 12:1420–32, 1990.PubMedCrossRefGoogle Scholar
  57. 57.
    Epstein B, Ettinger D, Leichner P, Order SE. Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma. Cancer 67:896–900, 1991.PubMedCrossRefGoogle Scholar
  58. 58.
    Beasley RP. Hepatitis B virus. Cancer 61:1942–56, 1988.PubMedCrossRefGoogle Scholar
  59. 59.
    Wands JR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med 325:729–31, 1991.PubMedCrossRefGoogle Scholar
  60. 60.
    de Franchis IT, Meucci G, Vecchi M, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191–4, 1993.PubMedGoogle Scholar
  61. 61.
    Simonetti RG, Cammi C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 116:97–103, 1992.PubMedGoogle Scholar
  62. 62.
    Tabor E, Kobayashi K. Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: prevalence and structure-Summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma. J Natl Cancer Inst 84:86–90, 1992.PubMedCrossRefGoogle Scholar
  63. 63.
    Tsukama H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797–1801, 1993.CrossRefGoogle Scholar
  64. 64.
    Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 52(Suppl):2114–8S, 1992.Google Scholar
  65. 65.
    Deugnier YK Guyader D, Crantock L, et al. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 104:228–34, 1993.PubMedGoogle Scholar
  66. 66.
    Iwatsuki S, Starzl TE. Personal experience with 411 hepatic resections. Ann SWg 208:421–434, 1988.Google Scholar
  67. 67.
    Theise ND, Schwartz M, Miller C, Thung SN. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver expiants with cirrhosis. Hepatology 16:949–55, 1993.CrossRefGoogle Scholar
  68. 68.
    Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming KP, Busuttil RW. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125:1261–6, 1990.PubMedCrossRefGoogle Scholar
  69. 69.
    Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 209:88–98, 1989.PubMedCrossRefGoogle Scholar
  70. 70.
    Iwatsuki S, Gordon RD, Shaw BJ, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 202:401–7, 1985.PubMedCrossRefGoogle Scholar
  71. 71.
    Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–93, 1990.PubMedGoogle Scholar
  72. 72.
    Yokoyama I, Sheahan DG, Carr B, et al. Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 23:2194–6, 1991.PubMedGoogle Scholar
  73. 73.
    McPeake JR, O’Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determines outcome. J Hepatol 18:226–34, 1993.PubMedCrossRefGoogle Scholar
  74. 74.
    Pichlmayr R, Ringe B, Wittekind C, et al. Liver grafting for malignant liver tumors. Transplant Proc 21:2403–5, 1989.Google Scholar
  75. 75.
    Hermanek P, Sobin LH. TNM Classification of Malignant Tumors. 4th ed. Berlin: Springer-Verlag, 1987.CrossRefGoogle Scholar
  76. 76.
    Stone MJ, Klintmalm GBG, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 104:196–202, 1993.PubMedGoogle Scholar
  77. 77.
    Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 63:387–94, 1992.CrossRefGoogle Scholar
  78. 78.
    Bismuth H, Chiche L, Adam R, Castaing D. Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation? Transplant Proc 25:1066–7, 1993.PubMedGoogle Scholar
  79. 79.
    Friedman MA. Chemotherapy for patients with hepatocellular carcinoma: Prospects and possibilities. In Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, TX, Gulf, 1991, pp, 287–292.Google Scholar
  80. 80.
    Steinherz U, Steinherz PG. Delayed anthracycline cardiac toxicity. Principles Pract Oncol 5:1–15, 1991.Google Scholar
  81. 81.
    Chemotherapy and hepatitis B (editorial). Lancet 2:1136–7, 1989.Google Scholar
  82. 82.
    Vogt DP. Current management of cholangiocarcinoma. Oncology 2:37–43, 1988.PubMedGoogle Scholar
  83. 83.
    Kanematsu T, Furuta T, Takenaka K, et al. A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10:98–102, 1989.PubMedCrossRefGoogle Scholar
  84. 84.
    Venook AP, Stagg RJ, Lewis BJ, et al. Chemoembolization for hepatocellular carcinoma. J Clin Oncol 8:1108–14, 1990.PubMedGoogle Scholar
  85. 85.
    Yamashita Y, Takahashi M, Koga Y, et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 67:385–91, 1991.PubMedCrossRefGoogle Scholar
  86. 86.
    Raoul JI, Bretagne JF, Caucanas JP, et al. Internal radiation therapy for hepatocellular carcinoma. Cancer 69:346–52, 1992.PubMedCrossRefGoogle Scholar
  87. 87.
    Yu Y, Xu D, Zhou X, et al. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 71:62–5, 1993.PubMedCrossRefGoogle Scholar
  88. 88.
    Kanematsu T, Matsumata T, Shirabe K, et al. A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. Cancer 71:2181–6, 1993.PubMedCrossRefGoogle Scholar
  89. 89.
    Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 69:925–9, 1992.PubMedCrossRefGoogle Scholar
  90. 90.
    Tanaka K, Nakamura S, Numata. K, et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185:457–60, 1992.PubMedGoogle Scholar
  91. 91.
    Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients. Am J Roentgenol 160:1023–8, 1993.CrossRefGoogle Scholar
  92. 92.
    Lai CI, Lau JYN, Wu PC, et al. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 17:389–94, 1993.PubMedCrossRefGoogle Scholar
  93. 93.
    Farinati F, Salvagnini M, de Maria N, et al. Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol 11:297–301, 1990.PubMedCrossRefGoogle Scholar
  94. 94.
    Carlson RI, Ben-Porath E, Shouval D, et al. Antigenic characterization of human hepatocellular carcinoma. J Clin Invest 76:40–51, 1985.PubMedCrossRefGoogle Scholar
  95. 95.
    Takahashi H, Ozturk M, Vilson B, et al. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma. Hepatology 9:625–34, 1989.PubMedCrossRefGoogle Scholar
  96. 96.
    Keegan-Rogers V, Wu GY. Immunotargeting in the diagnosis and treatment of liver cancer. Hepatology 9:646–8, 1989.PubMedCrossRefGoogle Scholar
  97. 97.
    Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218:145–51, 1993.PubMedCrossRefGoogle Scholar
  98. 98.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–9, 1996.PubMedCrossRefGoogle Scholar
  99. 99.
    Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434–40, 1999.PubMedCrossRefGoogle Scholar
  100. 100.
    Kanematsu T, Takenaka K, Furuta T, et al. Acute portal hypertension associated with liver resection. Analysis of early postoperative death ArchSWg 120:1303–5, 1985.Google Scholar
  101. 101.
    Elias D, Debaere T, Roche A, et al. Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver. Hepatogastroenterology 45:170–7, 1998.PubMedGoogle Scholar
  102. 102.
    Marcos A, Ham JM, Fisher RN, et al. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 6:296–301,2000.PubMedCrossRefGoogle Scholar
  103. 103.
    Starzl TE, Iwatsuki S, Shaw BJ, Nalesnik MA, Farhi DC, Van Thiel D. Treatment of fibrolamellär hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 162:145–8, 1986.PubMedGoogle Scholar
  104. 104.
    Nakajima T, Kondo Y, Miyazald M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma. Hum Pathol 19:1228–34, 1988.PubMedCrossRefGoogle Scholar
  105. 105.
    Ma CK, Zarbo RJ, Frierson HF, Lee MW. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 99:551–7, 1993.PubMedGoogle Scholar
  106. 106.
    Swanson PE. Diagnostic immunohistochemistry. Am J M Pathol 99:530–2, 1993.Google Scholar
  107. 107.
    Wanebo HJ, Ahlgren JD, Macdonald JS, eds. Gastrointestinal Oncology. Philadelphia, JB Lippincott 1992, pp399–416Google Scholar
  108. 108.
    Chen MF, Jan YY, Wang CS, et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer 64:2226–32, 1989.PubMedCrossRefGoogle Scholar
  109. 109.
    Farrant JM, Hayliar KM, Wilkinson ML, et al Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100:1710–7, 1991.PubMedGoogle Scholar
  110. 110.
    Calne RY. Liver transplantation for liver cancer. World J Surg 10:76–80, 1986.CrossRefGoogle Scholar
  111. 111.
    Iwatsuki S, Klintmalm GBG, Starzl TE. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg 6:81–5, 1982.PubMedCrossRefGoogle Scholar
  112. 112.
    Neuhaus P, Proelsch C, Ringe B, Pichlmayr R. Liver transplantation for liver tumors. In: Herfarth C, Schlag P, Hohenberger P, eds. Therapeutic Strategy in Primary and Metastatic Liver Cancer. New York: Springer Verlag, 1986:221–8.CrossRefGoogle Scholar
  113. 113.
    Weiss JW, Enzinger FM. Epithelioid haemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 50:970–81, 1982.PubMedCrossRefGoogle Scholar
  114. 114.
    Forbes A, Portmann B, Johnson P, Williams R. Hepatic sarcomas in adults: a review of 25 cases. Gut 28:668–74, 1987.PubMedCrossRefGoogle Scholar
  115. 115.
    Marino IR, Todo S, Tzakis AG, et al. Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 62:2079–84, 1988.PubMedCrossRefGoogle Scholar
  116. 116.
    Kelleher MB, Iwatsuld S, Sheahan DG. Epithelioid hemangioendothelioma of liver. Am JSurg Pathol 13:999–1008, 1989.CrossRefGoogle Scholar
  117. 117.
    Yokoyama I, Carr B, Saitsu HL, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68:2095–2100, 1991.PubMedCrossRefGoogle Scholar
  118. 118.
    Busuttil R, Klintmalm G, eds. Transplantation of the Liver, Philadelphia, WB Saunders 1996, pp 130–133Google Scholar
  119. 119.
    Arnold JC, O’Grady JG, Bird GL, Caine RY, Williams R. Liver transplantation for primary and secondary hepatic apudomas. Br J Surg 76:248–9, 1989.PubMedCrossRefGoogle Scholar
  120. 120.
    Makowka L, Tzakis AG, Mazzaferro V, et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 168:107–11,1989.PubMedGoogle Scholar
  121. 121.
    Lobe TE, Vera SR, Bowman LC, Fontanesi J, Britt, LG, Gaber AO. Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood. J Pediatr Surg 27:227–9, 1992.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2001

Authors and Affiliations

  • Alan Koffron
    • 1
  • Jonathan P. Fryer
    • 1
  • Michael Abecassis
    • 1
  1. 1.Northwestern University Medical SchoolChicagoUSA

Personalised recommendations